EricLawrenceSmithMD

PubMed

• 24 citations
  Growth hormone response to clonidine in adversely reared young adult primates: relationship to serial cerebrospinal fluid corticotropin-releasing factor concentrations.
  Jeremy D. Coplan, Eric L. Smith, Ronald C. Trost, Bruce Scharf, Margaret Altemus
  Psychiatry Research. 2000-08-21
• 23 citations
  Maternal-infant response to variable foraging demand in nonhuman primates: effects of timing of stressor on cerebrospinal fluid corticotropin-releasing factor and circ...
  Jeremy D. Coplan, Eric L. Smith, Margaret Altemus, Sanjay J. Mathew, Tarique D. Perera
  Annals of the New York Academy of Sciences. 2006-07-01
• 7 citations
  Effects of Acute Confinement Stress-induced Hypothalamic-pituitary Adrenal Axis Activation and Concomitant Peripheral and Central Transforming Growth Factor-β1 Measure...
  Jeremy D. Coplan, Srinath Gopinath, Chadi G. Abdallah, Jeffrey Margolis, Wei Chen
  Chronic Stress. 2017-02-17

Abstracts/Posters

• MALDI-TOF Mass Spectrometry in Serum for the Follow-up of Newly Diagnosed Multiple Myeloma Patients Treated with Daratumumab-Based Combination Therapy
  Eric L Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Multiple Myeloma Patients Treated with Lenalidomide Maintenance Therapy: A Clinical and Correlative Ph...
  Eric L Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Multiple Myeloma Patients Treated with Lenalidomide Maintenance Therapy: A Clinical and Correlative Ph...
  Eric L Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Hematological Count Recovery in Patients Undergoing Treatment with Chimeric Antigen Receptor T Cells (CAR T)
  Eric L Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Weekly Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab (wKRd-D) Combination Therapy Provides Unprecedented MRD Negativity Rates in Newly Diagnosed Multiple My...
  Eric L Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Optimal Dual-Targeted CAR Construct Simultaneously Targeting Bcma and GPRC5D Prevents Bcma-Escape Driven Relapse in Multiple Myeloma
  Eric L Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• VTE Rates and Safety Analysis of Newly Diagnosed Multiple Myeloma Patients Receiving Carfilzomib-Lenalidomide-Dexamethasone (KRD) with or without Rivaroxaban Prophylaxis
  Eric L Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Comparison of MALDI-TOF Mass Spectrometry Analysis of Peripheral Blood and Bone Marrow Based Flow Cytometry for Tracking Measurable Residual Disease (MRD) in Patients ...
  Eric L Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all